Home
BBI Life Sciences Corporation

BBI Life Sciences Corpor... Market Share Analysis for July 2026

Industry: N/A

Domainbbi-lifesciences.com

Year Founded2001

Employees1001 - 5000

Annual Revenue$75M - $100M

BBI Life Sciences Corporation

BBI Life Sciences Corporation (including company regionals)

bbi-lifesciences.com

See more website traffic and engagement information

BBI Life Sciences Corporation Revenue up to July 2026 is 75M - 100M

revenue generated by BBI Life Sciences Corporation top domains

BBI Life Sciences Corporation top domains revenue over 3 years

Revenue for BBI Life Sciences Corporation top domains

bbi-lifesciences.com75M - 100M

See more with Sales Intelligence

Total visits to BBI Life Sciences Corporation's top domains

Understand BBI Life Sciences Corporation market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in BBI Life Sciences Corporation's top domains

Analyze BBI Life Sciences Corporation engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on BBI Life Sciences Corporation's top domains

See how BBI Life Sciences Corporation keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

BBI Life Sciences Corporation top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by BBI Life Sciences Corporation

These are the website technologies, by industry, used by BBI Life Sciences Corporation top domains

Advertising (2)

PubMatic

Conversion & Analytics (1)

Baidu Analytics

Email Services (1)

QQ Mail

Mobile (1)

Meta Viewport

More Technologies

1

See all

News & Signals from BBI Life Sciences Corporation

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSINOPHARM Group acquires Bbi Lifesciences for $1B.China’s state-run drugmaker Sinopharm is considering a US$1 billion deal to acquire BBI Life Sciences, a Shanghai-based producer of DNA synthesis and genetic engineering products, according to a report from Bloomberg.

NewsBbi Lifesciences had earnings of $33.9M on Jul 1st '17.BBI Life Science (HK: 01035) announced that in 2017, the revenue of the group was approximately RMB 462 million, representing an increase of 31.4%; gross profit was approximately RMB 231 million, a year-on-year increase of 25.4%; profit attributable to equity holders of the Company increased by 7.1% to approximately RMB 64.45 million, basic earnings per share was RMB 0.118, and final dividend was HKD 0.014 per share.